Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5562 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 28 29 30 ... 54 55 56  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Filgen–Metabolomic Discoveries: metabolomics, 201404– distribution excl of Metabolomic Discoveries’ technologies in Japan by Filgen 2014-04-25
Biobase–Murdoch Childrens Research Institute: POSSUMweb database, 201404– distribution ww excl by Biobase GmbH 2014-04-24
Boehringer–Hydra Biosciences: CNS drugs, 201404– collab ww r+d small-molecule TRPC4/5 inhibitors for CNS diseases 2014-04-24
Clal Industries–Hyperion Therapeutics: investment, 201404–201406 acquisition of Andromeda Biotech for $12.5m in cash + 313k shares 2014-04-24
CRISPR Therapeutics–Versant Ventures: investment, 201404 financing round Series A $25m from Versant Ventures 2014-04-24
Isarna Therapeutics–SEVERAL: investment, 201404 financing round €5.5m from existing investors incl ATNewTec + Global Asset Fonds + MIG 2014-04-24
European ScreeningPort–Fraunhofer: investment, 201406 restructuring of ESP becoming part of Fraunhofer IME 2014-04-23
GSK–Novartis: OTC drugs, 201404–201503 collab establishment of OTC joint venture with Novartis owning 36.5% 2014-04-22
Novartis–GSK: cancer drugs, 201404–201503 acquisition $14.5b + $1.5b milestones of GSK oncology products + opt in GSK oncology pipeline 2014-04-22
Novartis–GSK: investment, 201404–201503 acquisition $5.25b upfront + $1.8b milestones + royalties of Novartis vaccine business excluding flu business 2014-04-22
Novartis–Lilly: investment, 201404–201501 acquisition $5.4b in cash of Novartis Animal Health Divison by Eli Lilly 2014-04-22
High-Tech Gründerfonds–Bayer: investment, 201404 investment of Bayer Pharma AG in High-Tech Gründerfonds II 2014-04-19
Daiichi Sankyo–Max Planck: drug discovery services, 201404– supply screening services by LDC using LDC + Daiichi compound libraries 2014-04-17
4SC–EU (govt): grant, 201404– €450k grant for 4SC Discovery GmbH as part of the CV genes-at-target project 2014-04-15
Biocartis–Danaher: Evalution multiplex detection platform, 201404– collab + supply co-developm + manufacturing by Invetech 2014-04-15
Essen BioScience–SFW Capital Partners: investment, 201405 strategic investment in Essen BioScience by SFW 2014-04-15
Diana–Symrise: investment, 201404– planned acquisition €1.3b ANNOUNCED 2014-04-12
Qiagen–Austrian Academy of Sciences: biomarker, 201404– license excl ww to biomarker calreticulin (CALR) from CeMM Vienna 2014-04-10
Omni Life Science–ACEA Biosciences: cell analysis technology, 201404 collab OLS is excl distributor for ACEA in Austria 2014-04-09
Omni Life Science–ACEA Biosciences: cell analysis technology, 201404 collab OLS is excl distributor for ACEA in Germany 2014-04-09
Piqur Therapeutics–SEVERAL: investment, 201404 financing round Series A extension CHF18m led by Versant Ventures with CHF11m 2014-04-08
Piqur Therapeutics–Versant Ventures: investment, 201404 financing round Series A extension totalling CHF18m incl CHF11m from Versant Ventures 2014-04-08
Protea Biosciences–Bruker Corp: mass spectrometer, 201404 supply + installation of UltrafleXtreme MALDI TOF/TOF mass spectrometer for MS imaging 2014-04-08
IQuum–Roche: investment, 201404 acquisition $275m upfront + $175m milestones 2014-04-07
Roche–Oryzon Genomics: LSD1 inhibitors, 201404–201707 collab $21m upfront + short-term milestones + $500m milestones + royalties TERMINATED 7/17 2014-04-07
Roche–Oryzon Genomics: LSD1 inhibitors, 201605–201707 collab extension developm of ORY-1001 TERMINATED 7/17 2014-04-07
Merck (DE)–Auxogyn: IVF test, 201404– license excl for commercialisation of Eeva Test in Europe + Canada to Merck Serono 2014-04-03
Debiopharm–Evotec: drug discovery services, 201404– collab + licensing discovery + developm of cancer drugs 2014-04-02
Bayer–Targenomix: plant target discovery, 201404–201903 collab 5y to discover molecular targets in plants using systems biology 2014-04-01
EcoMetals project–BRAIN: industrial biotechnology, 201404– collab BRAIN AG is industrial project partner in German-French EcoMetals research programme 2014-04-01
EcoMetals project–Germany (govt): grant, 201404– funding €4,2m from BMBF for 7 German project partners 2014-04-01
EcoMetals project–Helmholtz: industrial biotechnology, 201404– collab HZDR is lead scientific project partner in EcoMetals research programme 2014-04-01
Pierre Fabre–Affimed: antibody technology, 201404– collab use of AbCheck’s AbSieve discovery platform to discover ABs against targets of CIPF 2014-04-01
Roche–Hitachi: immunoassay + chemical analyser, 201404–202403 collab strategic alliance developm + production 10y extension 2014-04-01
Trinean–Sony: microfluidics disposables, 201404– supply OEM for DropSense96 spectrometer + Xpose Touch&Go sample QC analyzer by Sony DADC BioSciences 2014-04-01
Convergence Pharmaceuticals–Evotec: drug discovery services, 201403– collab €na pain drug r+d with Panion Ltd 2014-03-31
Convergence Pharmaceuticals–United Kingdom (govt): grant, 201403c– Biomedical Catalyst grant £2.4m to develop drug against novel GPCR pain target 2014-03-31
Singulex–Sony: microtitre plates, 201403– supply of customised detection vessels as microtitre plate for Sgx Clarity System by Sony DADC BioSciences 2014-03-31
Univ Oulu–Bruker Corp: mass spectrometer, 201403 supply existent UltrafleXtreme MALDI Tof/Tof listed on web site of MS Core Facility 2014-03-30
Anatech Instruments–Fortis Technologies: HPLC columns, 201403 distribution existent in South Africa by Anatech Instruments 2014-03-29
Dichrom–Fortis Technologies: HPLC columns, 201403 distribution existent in Germany by Dichrom 2014-03-29
Genmab–MAB Discovery: drug discovery services, 201403– collab €na generation of antibodies for multiple Genmab targets 2014-03-27
MAB Discovery–MC Services: public relations, 201403 service existent for MAB Discovery GmbH 2014-03-27
Singulex–Tecan: automated liquid handling, 201403– collab developm of Sgx Clarity System using Freedom EVO platform 2014-03-25
Bionamics–Evotec: investment, 201403 acquisition €na 100% against cash + future milestone payments 2014-03-24
Evotec–Reach Separations: chromatography, 201403– collab with Reach becoming technology partner providing small molecule chromatography 2014-03-19
Ipca Laboratories–Reach Separations: chromatography, 201403 collab existent offer custom separation services with Onyx Scientific 2014-03-19
Seltenerden Storkwitz–BRAIN: industrial biotechnology, 201403– collab expansion strategic partnership biotech extraction of rare earth metals 2014-03-19
Thermo Fisher–Harvard Univ: mass spectrometry, 201403– collab establ Center for Multiplexed Proteomics + develop methods + trainings w Prof Gygi 2014-03-19
Prionics–Thermo Fisher: investment, 201403 acquisition by Thermo Fisher 2014-03-17
Sysmex–Merck (DE): flow cytometry, 201404– collab research + licensing + co-developm agreem to use Amnis imaging flow cytometry for blood diagnostics 2014-03-17
Activaero–Vectura: investment, 201403 acquisition €130m with €45m cash upfront + €35m in Aug 2015 + €50m in shares 2014-03-13
Inotrem–BioMedPartners: investment, 201403 financing round Series A totalling €18m incl co-investor BioMedInvest II fund 2014-03-13
Inotrem–LCF Rothschild: investment, 201403 financing round Series A totalling €18m co-led by EdRIP + Sofinnova Partners 2014-03-13
Inotrem–MC Services: public relations, 201403 service existent for Inotrem SA 2014-03-13
Inotrem–SEVERAL: investment, 201403 financing round Series A €18m co-led by EdRIP + Sofinnova Partners 2014-03-13
Qiagen–SEVERAL: credit, 201403–2019 convertible notes $430m at 0.375% 2014-03-12
Qiagen–SEVERAL: credit, 201403–2021 convertible notes $300m at 0.875% to repay outstanding $291m notes due 2026 2014-03-12
Chemie.DE–Köhl et Feling: public relations, 201403 service existent for Chemie.DE Information Service GmbH 2014-03-11
Exosome Diagnostics–Arcus Ventures: investment, 201403 financing round Series B totalling $27m co-led by Qiagen + Arcus Ventures 2014-03-11
Exosome Diagnostics–Forbion: investment, 201403 financing round Series B totalling $27m incl returning co-investors NGN Capital + Forbion 2014-03-11
Exosome Diagnostics–NGN Capital: investment, 201403 financing round Series B totalling $27m incl returning co-investors NGN Capital + Forbion 2014-03-11
Exosome Diagnostics–Qiagen: investment, 201403 financing round Series B totalling $27m co-led by Qiagen + Arcus Ventures 2014-03-11
Exosome Diagnostics–SEVERAL: investment, 201403 financing round Series B $27m co-led by Qiagen + Arcus Ventures 2014-03-11
Glycotope–Eckert Wagniskapital: investment, 201403 financing round totalling €55m from Jossa Arznei GmbH + ELSA GmbH 2014-03-11
Glycotope–SEVERAL: investment, 201403 financing round €55m from Jossa Arznei GmbH + ELSA GmbH 2014-03-11
Glycotope–Strüngmann Group: investment, 201403 financing round totalling €55m from Jossa Arznei GmbH + ELSA GmbH 2014-03-11
Biognosys–ETH Zürich: mass spectrometry s/w, 201403– collab testing of SpectroDive PRM s/w by FGCZ 2014-03-07
Immunexpress–Debiopharm: investment, 201403 financing round totalling $6m incl lead investor Debiopharm Diagnostics SA 2014-03-05
Immunexpress–SEVERAL: investment, 201403 financing round $6m led by Debiopharm 2014-03-05
4SC–Yorkville Group: credit, 201403 first tranche €500k convertible notes under up to €15m agreem from 2/14 w YA Global Master SPV Ltd 2014-03-04
Merus–Minapharm: GlymaxX technology, 201403– non-excl option + license agreem €na for use for bispecific cancer antibody from ProBioGen AG 2014-03-04
Agilent–Schauenburg: Unity-Air Server system, 201403 collab existent product integration of Unity into Agilent/Markes TD-GC-dual FID system 2014-03-01
BRAIN–Germany (govt): grant, 201403– BMBF funding for collab BRAIN + Selterden Storkwitz to develop bio-mining pilot plant for rare earth metals 2014-03-01
OPI (CH)–OSE Pharma: investment, 201403 acquisition of assets of OPI SA (Geneva) incl rights to Memopi technology 2014-03-01
Thermo Fisher–Schauenburg: Unity-Air Server system, 201403 collab existent product integration of Unity into Thermo Scientific/Markes TD-GC-MS system 2014-03-01
Gerstel–Spark Holland: dried blood spot technology, 201402– supply OEM incl FTD technology + DBS Autosampler for automated DBS systems of Gerstel 2014-02-28
Roche–Discuva: antibiotics, 201402– collab + license ww $16m upfront + $175m milestones per product + royalties r+d using SATIN technology 2014-02-28
Transgene–SEVERAL: investment, 201402 rights issue €45.5m with subscription rights €10/share 2014-02-28
microDimensions–High-Tech Gründerfonds: investment, 201402 seed financing round with HTGF + Bayern Kapital + business angel Adriaan Hart de Ruijter 2014-02-27
microDimensions–SEVERAL: investment, 201402 seed financing round with HTGF + Bayern Kapital + business angel Adriaan Hart de Ruijter 2014-02-27
BRAIN–BASF: food ingredients, 201402 acquisition of anti-bitter patents + utility patents from BASF by BRAIN 2014-02-25
Evolva–SEVERAL: investment, 201402–201403 private placement CHF42.5m with 27m+5.5m new shares CHF1.37/share 2014-02-25
Sysmex–Roche: PCR technology, 201402– license ww non-excl for emPCR patent portfolio to Sysmex Inostics GmbH 2014-02-21
Amal Therapeutics–Boehringer: investment, 201402 seed funding round from Boehringer Ingelheim Venture Fund + HTGF 2014-02-20
Amal Therapeutics–High-Tech Gründerfonds: investment, 201402 seed funding round from Boehringer Ingelheim Venture Fund + HTGF 2014-02-20
Amal Therapeutics–SEVERAL: investment, 201402 seed funding round from Boehringer Ingelheim Venture Fund + HTGF 2014-02-20
Proteros–MC Services: public relations, 201402 service existent for Proteros Biostructures GmbH 2014-02-20
Centogene–OMERS (CA): investment, 201402 acquisition of Centogene’s Canadian business by LifeLabs 2014-02-19
Novimmune–SEVERAL: investment, 201402 financing round Series B CHF60m led by Rosetta Capital Ltd 2014-02-18
Synaffix–Aravis: investment, 201402 financing round Series A incl Aravis + BioGeneration Ventures + MS Ventures + BOM Capital 2014-02-18
Synaffix–BioGeneration Ventures: investment, 201402 financing round Series A incl Aravis + BioGeneration Ventures + MS Ventures + BOM Capital 2014-02-18
Synaffix–BOM Capital: investment, 201402 financing round Series A incl Aravis + BioGeneration Ventures + MS Ventures + BOM Capital 2014-02-18
Synaffix–Merck (DE): investment, 201402 financing round Series A incl Aravis + BioGeneration Ventures + MS Ventures + BOM Capital 2014-02-18
Synaffix–SEVERAL: investment, 201402 financing round Series A incl Aravis + BioGeneration Ventures + MS Ventures + BOM Capital 2014-02-18
Advanced Accelerator Applications–SEVERAL: investment, 201402 financing round €41m capital increase led by HBM Healthcare w €20m 2014-02-17
CoStim Pharmaceuticals–Novartis: investment, 201402 acquisition €na 2014-02-17
Horizon Discovery–Sirion Biotech: genomic technology, 201402– supply to + distribution of RANiONE based services + reagents by Horizon 2014-02-17
4SC–Yorkville Group: credit, 201402– up to nominally €15m convertible notes to be purchased until 12/16 by YA Global Master SPV Ltd 2014-02-12
Coramaze Technologies–High-Tech Gründerfonds: investment, 201402 seed funding round totalling €1m co-led by HTGF + Seed Capital Dortmund 2014-02-12
next pagenext page 1 2 3 ... 28 29 30 ... 54 55 56  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top